08 Dec, 2025,

BREAKING NEWS: JioStar Abandons $3 Billion ICC Deal Amid Massive Losses - IPL's Future Valuation in Jeopardy

In a dramatic development that threatens to reshape India's cricket broadcasting landscape, Reliance Industries-controlled JioStar has formally notified the International Cricket Council (ICC) th...

08 Dec, 2025,

1701 3

27 Jun, 2023,

170 0

API Holdings Set To Demerge Mahaveer Medicos Under Ascent Wellness And...

API Holdings Announces a Strategic Business Meeting API Holdings is scheduled to hold an important strategic business meeting via video conferencing on the 27th of July, 2023, at 12 Noon. The purpose of this conference is to discuss the demerger of the Mahaveer Medicos business and its subsequent amalgamation under Ascent Wellness and Pharma. Business Overview: The Involved Entities Mahaveer Medic...

27 Jun, 2023,

170 0

12 Jun, 2023,

122 0

PharmEasy Appoints Avendus Capital for Equity Funding

Introduction: PharmEasy, a prominent online pharmacy platform, has recently announced its partnership with Avendus Capital to raise equity funding. This move comes as PharmEasy aims to secure additional funds to meet a crucial covenant in the loan it received from Goldman Sachs. The company's existing investors, including Prosus Ventures, Temasek Holdings, CDPQ, and TPG, have expressed interest in...

12 Jun, 2023,

122 0

24 May, 2023,

79 0

PharmEasy mails health ministry for quick draft rules notification.

1. API Holdings, the parent company of PharmEasy, has requested the Union Health Minister, Mansukha Mandaviya, to expedite the notification of draft e-pharmacy rules. 2. The request comes after the Drug Controller General of India (DCGI) issued show-cause notices to about 20 online pharmacies for alleged violation of norms in February. 3. API Holdings, in a letter to the Health Minister, asked f...

24 May, 2023,

79 0

15 May, 2023,

47 0

Janus Henderson Marks Down Pharmeasy's Valuation by Half to $2.8Bn

Global Investors Mark Down PharmEasy Valuation Amid Financial Struggles and Broader Tech Downturn 1. Markdown in PharmEasy's Valuation: According to regulatory filings with the US Securities and Exchange Commission (SEC), API Holdings, the parent company of Mumbai-based online pharmacy PharmEasy, has seen a significant markdown in valuation by funds managed by global asset management company Janus...

15 May, 2023,

47 0

19 Oct, 2022,

212 0

Excerpts from the Interview of Co-founder of Pharmeasy with Times Now.

Ques. Why have you decided to not go ahead with the IPO? I think there are a couple of factors first and foremost, I think the companies on a very different and rapidly evolving trajectory while our companies had tremendous amount of growth for these last few years and we've grown more than 50% consistently we believe that going ahead the focus of the company must be on growth as well as profitab...

19 Oct, 2022,

212 0

22 Sep, 2022,

155 0

Pharmeasy Right Issue at Rs.100 opening from 21.09.2022. Should You Ap...

Basic Details API holding, the parent company of Pharmeasy, is going to conduct the rights issue to raise funds and strengthen the valuation of the company amid weak market conditions. 1. As per the letter of offer, the size of the right issue is Rs. 750 crore at the price of Rs. 100 per right issue. 2. The entitlement ratio is 1:82, which means for 1 CCPS, a shareholder must have 82 equity share...

22 Sep, 2022,

155 0

11 Nov, 2021,

196 0

Pharmeasy parent API Holdings filed DRHP for Rs 6250 crore IPO

PharmEasy, a leading name in India's e-pharmacy sector, has recently made a significant move towards its growth trajectory by filing for an Initial Public Offering (IPO). API Holdings, PharmEasy's parent company, has submitted a Draft Red Herring Prospectus (DRHP) to SEBI, the capital markets regulator. This step marks a pivotal point in PharmEasy's journey, aligning with the trend of public issue...

11 Nov, 2021,

196 0